This single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.
Peter Millin, PharmD Candidate
Advertisement
Articles by Peter Millin, PharmD Candidate
Advertisement
Latest Updated Articles
- Rx Product News: Profile: A Closer Look at New FDA Actions: Nuvigil
Published: June 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Interview with Sa'ed al-Olimat, PharmD: How Pharmacists are Shaping the Future of Psychedelic Therapy
2
December 2025 Product Updates
3
A Healthy Gut Could Improve Mental Health
4
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
5